Type
Colebunders R, Siewe Fodjo JN, Kamoen O, Amaral L-J, Hadermann A, Trevisan C, et al. Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed. Infectious Diseases of Poverty [Internet]. 2024;13(1):1-5. Available from: https://mednexus.org/doi/pdf/10.1186/s40249-024-01174-8
Type
Olowu O, Nwankwo A, Ako I. Analytical Investigation of the Impact of Failed Treatments on the Transmission Dynamics of Onchocerciasis. International Journal of Mathematics Trends and Technology [Internet]. 2024;70(4):1-8. Available from: https://www.researchgate.net/profile/Owin-Olowu/publication/379832949_Analytical_Investigation_of_the_Impact_of_Failed_Treatments_on_the_Transmission_Dynamics_of_Onchocerciasis/links/661d8e3843f8df018d0e49b4/Analytical-Investigation-of-the-Impact-of-Faile
Type
Van Cutsem G, Siewe Fodjo JN, Hadermann A, Amaral L-J, Trevisan C, Pion S, et al. Onchocerciasis-Associated Epilepsy: charting a path forward. Seizure: European Journal of Epilepsy. 2024;.
Type
Mutono N, Basáñez M-G, James A, Stolk WA, Makori A, Kimani TN, et al. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health [Internet]. 2024;:1-12. Available from: https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900043-3
Type
Masiyiwa T, Bockarie MJ. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Internet]. 2024;. Available from: https://www.ijidonline.com/action/showPdf?pii=S1201-9712%2824%2900017-1
Type
Domche A, Nana Djeunga HC, Nwane PB, Njitchouang GR, Nono Fesuh B, Njiokou F, et al. Significant reduction of blackfly densities in persistent onchocerciasis area following pilot implementation of an environment friendly approach (Slash and Clear). Scientific Reports [Internet]. 2024;14(1):1-10. Available from: https://www.nature.com/articles/s41598-023-50747-4.pdf
Type
Mushi V, Mmbando BP, Colebunders R. Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations. Tropical diseases, travel medicine and vaccines [Internet]. 2024;10(1):1-5. Available from: https://tdtmvjournal.biomedcentral.com/counter/pdf/10.1186/s40794-023-00211-y.pdf
Type
Yirgu R, Middleton J, Fekadu A, Davey G, Bremner S, Jones CI, et al. No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023;.
Type
Shintouo CM, Shey RA, Yengo BN, Yaah NE, Teh RN, Ngwese RA, et al. Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon. Acta Tropica. 2023;246.
Type
Eyang-Assengone E-R, Makouloutou-Nzassi P, Mbou-Boutambe C, Bangueboussa F, Atsame J, Boundenga L. Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review. Microorganisms [Internet]. 2023;11(8):1-11. Available from: https://www.mdpi.com/2076-2607/11/8/1946/pdf?version=1690634608